ACHELOIS AUTOCLONER
Target multiple molecules with precision
Achelois Biopharma, Inc.
Description
The enables scientists to design and analyze multivalent therapeutics for diseases like cancer and autoimmune disorders. It supports molecular modeling, compound selection, and experimental planning for drug development.
Achelois BioPharma develops curative, programmable Multivalent Therapeutics to treat cancer, viral infection, autoimmune, and inflammatory diseases. Unlike traditional drugs, which are designed to target a single molecule, multivalent therapeutics are designed to target a combination of molecules underlying complex human diseases. The Autocloner application assists scientists to discover and develop these novel treatments.